Literature DB >> 15906762

Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography.

Ryan D Madanick, Colm J O'Loughlin, Jamie S Barkin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15906762     DOI: 10.1007/s10620-005-2658-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  18 in total

1.  Complications of diagnostic and therapeutic ERCP: a prospective multicenter study.

Authors:  E Masci; G Toti; A Mariani; S Curioni; A Lomazzi; M Dinelli; G Minoli; C Crosta; U Comin; A Fertitta; A Prada; G R Passoni; P A Testoni
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

2.  Complications of ERCP.

Authors:  J Shawn Mallery; Todd H Baron; Jason A Dominitz; Jay L Goldstein; William K Hirota; Brian C Jacobson; Jonathan A Leighton; Hareth M Raddawi; John J Varg; J Patrick Waring; Robert D Fanelli; Jo Wheeler-Harbough; Glenn M Eisen; Douglas O Faigel
Journal:  Gastrointest Endosc       Date:  2003-05       Impact factor: 9.427

3.  Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.

Authors:  J Devière; O Le Moine; J L Van Laethem; P Eisendrath; A Ghilain; N Severs; M Cohard
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

4.  Complications of endoscopic sphincterotomy: results from a single tertiary referral center.

Authors:  M Barthet; N Lesavre; A Desjeux; M Gasmi; P Berthezene; S Berdah; X Viviand; J C Grimaud
Journal:  Endoscopy       Date:  2002-12       Impact factor: 10.093

5.  Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis.

Authors:  A Andriulli; G Leandro; G Niro; A Mangia; V Festa; G Gambassi; M R Villani; D Facciorusso; P Conoscitore; F Spirito; G De Maio
Journal:  Gastrointest Endosc       Date:  2000-01       Impact factor: 9.427

6.  Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.

Authors:  M L Freeman; J A DiSario; D B Nelson; M B Fennerty; J G Lee; D J Bjorkman; C S Overby; J Aas; M E Ryan; G S Bochna; M J Shaw; H W Snady; R V Erickson; J P Moore; J P Roel
Journal:  Gastrointest Endosc       Date:  2001-10       Impact factor: 9.427

7.  Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP?

Authors:  Thomas Rabenstein; Sylvia Roggenbuck; Baerbel Framke; Peter Martus; Bernhard Fischer; Gerhard Nusko; Steffen Muehldorfer; Juergen Hochberger; Christian Ell; Eckhart G Hahn; H Thomas Schneider
Journal:  Gastrointest Endosc       Date:  2002-04       Impact factor: 9.427

8.  Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?

Authors:  K F Binmoeller; A G Harris; R Dumas; C Grimaldi; J P Delmont
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

9.  Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial.

Authors:  Manuel Moretó; Manuel Zaballa; Ignacio Casado; Olga Merino; Miguel Rueda; Kléber Ramírez; Raquel Urcelay; Amaia Baranda
Journal:  Gastrointest Endosc       Date:  2003-01       Impact factor: 9.427

10.  The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy.

Authors:  R Arcidiacono; P Gambitta; A Rossi; C Grosso; M Bini; G Zanasi
Journal:  Endoscopy       Date:  1994-11       Impact factor: 10.093

View more
  1 in total

Review 1.  NSAIDs and Acute Pancreatitis: A Systematic Review.

Authors:  Raffaele Pezzilli; Antonio Maria Morselli-Labate; Roberto Corinaldesi
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.